RxDoctor Payments Data

Patricia Campbell, MD

Family Medicine · Petal, MSNPI 1255991253

Payments from drug & device makers

$426in general payments, 2019–2025

Across 23 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$191
  • Exact Sciences$84
  • AbbVie$45
  • Lilly USA, LLC$36
  • Baxter Healthcare$20
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$18
  • plus $33 from 2 others

What the payments were for

  • Food & beverage$426100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$426 in reported general payments places this provider in the 45th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$67,999
Medicare patients
196
Services billed
868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin42$56,739
OzempicSemaglutide35$38,743
MounjaroTirzepatide19$33,173
EliquisApixaban34$29,125
FarxigaDapagliflozin Propanediol16$21,207
TrulicityDulaglutide21$19,808
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,940
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,546
JanuviaSitagliptin Phosphate16$8,753
TrintellixVortioxetine Hydrobromide13$6,499
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$4,817
SymbicortBudesonide/Formoterol Fumarate14$3,303
Albuterol Sulfate HfaAlbuterol Sulfate106$2,989
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,631
Gabapentin155$2,565

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$36$52,98240 claims
Novo NordiskOzempic$191$38,74335 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$15$36,05548 claims
PfizerEliquis$17$29,12534 claims
AbbVieSynthroid$45$2,04922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Petal

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →